{
    "nct_id": "NCT06608277",
    "official_title": "Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Ketamine, Stellate Ganglion Blocks and Combination Treatment to Sham Therapies for Traumatic Brain Injury-Associated Headaches and Post-Traumatic Stress Disorder",
    "inclusion_criteria": "1. Adults 18 years or older\n2. Stable doses of medications for > 2 weeks for TBI and/or PTSD\n3. For TBI-associated headache with or without PTSD: HIT-6 score of >/=53. For PTSD with or without TBI-associated headache: PCL-5 score >/=33 OR. For those with TBI and PTSD, and a HIT-6 score < 53 and PCL-5 score of <33, individuals with a HIT-6 score of 50-52 and a PCL-5 score of 31 or 32 will be included.\n4. Duration of chronic TBI or PTSD > 3 months\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Ketamine infusion or SGB within the past 6 months\n2. Serious medical or psychiatric conditions other than TBI or PTSD that could affect cognition (e.g., dementia, Parkinson's Disease)\n3. Elevated intracranial pressure\n4. For TBI, prior history of headache that can explain the headache intensity (i.e., headache not attributable to TBI)\n5. Active psychosis or poorly controlled non-injury or PTSD-related psychiatric condition (e.g., bipolar disorder)\n6. Poorly controlled medical conditions that could be exacerbated by treatment (e.g., unstable angina)\n7. Pregnancy (women of childbearing age who can become pregnant will have to take a pregnancy test)\n8. Non-fluency in English (poor generalizability to military and veteran populations, instruments not validated for use or translated in many languages)",
    "miscellaneous_criteria": ""
}